Home
About
FAQ
History (4)
BSCI-17. Targeting SIRPa as a therapeutic strategy for the treatment of breast cancer brain metastasis. Neurooncol Adv
CLOVERS Protocol Committee and NHLBI Prevention and Early Treatment of Acute Lung Injury (PETAL) Network Investigators. Liberal Versus Restrictive Intravenous Fluid Therapy for Early Septic Shock: Rationale for a Randomized Trial
Co-Principal Investigator
Percutaneous cannulation for pediatric venovenous extracorporeal life support.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (13)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
Elsayed Z. Soliman MD, MS
Wake Forest School of Medicine
Why?
Mark C. Chappell PhD
Wake Forest School of Medicine
Why?
John Owen MD
Wake Forest School of Medicine
Why?
Steven J. Kridel PhD
Wake Forest School of Medicine
Why?
Ashish K. Khanna MD, FCCP, FCCM
Wake Forest School of Medicine
Why?
Carol A. Shively PhD
Wake Forest School of Medicine
Why?
Ryan C. Maves MD
Wake Forest School of Medicine
Why?
Debra I. Diz PhD
Wake Forest School of Medicine
Why?
Stephen Peters MD, PhD
Wake Forest School of Medicine
Why?
Herbert L. Bonkovsky MD
Wake Forest School of Medicine
Why?
Yusuke Takahashi PhD
Wake Forest School of Medicine
Why?
Aimee M. Wilkin MD, MPH
Wake Forest School of Medicine
Why?
Wei Zhang PhD
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 1
Next
Prev
Search Criteria
Protease Inhibitors
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions